(45) Peer Review--the review process performed by Scientific
Research and Prevention Programs Committee members and used by the
Institute to provide guidance and recommendations to the Program Integration
Committee and the Oversight Committee in making decisions for Grant
Awards. The process involves the consistent application of standards
and procedures to produce a fair, equitable, and objective evaluation
of scientific and technical merit, as well as other relevant aspects
of the Grant Application. When used herein, the term applies individually
or collectively, as the context may indicate, to the following review
process(es): Preliminary Evaluation, Individual Evaluation by Primary
Reviewers, Peer Review Panel discussion and Review Council prioritization.
(46) Peer Review Panel--a group of Scientific Research
and Prevention Programs Committee members conducting Peer Review of
assigned Grant Applications.
(47) Prevention Review Council--the group of Scientific
Research and Prevention Programs Committee members designated as the
chairpersons of the Peer Review Panels that review Cancer Prevention
program Grant Applications. This group includes the Review Council
chairperson.
(48) Primary Reviewer--a Scientific Research and Prevention
Programs Committee member responsible for individually evaluating
all components of the Grant Application, critiquing the merits according
to explicit criteria published in the Request for Applications, and
providing an individual Overall Evaluation Score that conveys the
general impression of the Grant Application's merit.
(49) Principal Investigator, Program Director, or Company
Representative--the single individual designated by the Grant Applicant
or Grant Recipient to have the appropriate level of authority and
responsibility to direct the project to be supported by the Grant
Award.
(50) Product Development Review Council--the group
of Scientific Research and Prevention Programs Committee Members designated
as the chairpersons of the Peer Review Panels that review Grant Applications
for the development of drugs, drugs, biologicals, diagnostics, or
devices arising from earlier-stage Cancer Research. This group includes
the Review Council chairperson.
(51) Product Development Prospects--the potential for
development of products, services, or infrastructure to support Cancer
Research efforts, including but not limited to pre-clinical, clinical,
manufacturing, and scale up activities.
(52) Program Income--income from fees for services
performed, from the use or rental of real or personal property acquired
with Grant Award funds, and from the sale of commodities or items
fabricated under the Grant Contract. Except as otherwise provided,
Program Income does not include rebates, credits, discounts, refunds,
etc. or the interest earned on any of these items. Interest otherwise
earned in excess of $250 on Grant Award funds is considered Program
Income.
(53) Program Integration Committee--the group composed
of the Chief Executive Officer, the Chief Scientific Officer, the
Chief Product Development Officer, the Commissioner of State Health
Services, and the Chief Prevention Officer that is responsible for
submitting to the Oversight Committee the list of Grant Applications
the Program Integration Committee recommends for Grant Awards.
(54) Project Results--all outcomes of a Grant Award,
including publications, knowledge gained, additional funding generated,
and any and all Technology and associated Intellectual Property Rights.
(55) Project Year--the intervals of time (usually 12
months each) into which a Grant Award is divided for budgetary, funding,
and reporting purposes. The effective date of the Grant Contract is
the first day of the first Project Year.
(56) Real Property--land, including land improvements,
structures and appurtenances thereto, excluding movable machinery
and equipment.
(57) Relative--a person related within the second degree
by consanguinity or affinity determined in accordance with §§573.021
- 573.025, Texas Government Code. For purposes of this definition:
(A) examples of an individual within the second degree
by consanguinity are a child, grandchild, parent, grandparent, brother,
sister;
(B) a husband and wife are related to each other in
the first degree of affinity. For other relationship by affinity,
the degree of relationship is the same as the degree of the underlying
relationship by consanguinity;
(C) an individual adopted into a family is considered
a Relative on the same basis as a natural born family member; and
(D) an individual is considered a spouse even if the
marriage has been dissolved by death or divorce if there are surviving
children of that marriage.
(58) Request for Applications--the invitation released
by the Institute seeking the submission of Grant Applications for
a particular Grant Mechanism. It provides information relevant to
the Grant Award to be funded, including funding amount, Grant Review
Process information, evaluation criteria, and required Grant Application
components. The Request for Applications includes any associated written
instructions provided by the Institute and available to all Grant
Applicants.
(59) Review Council--the term used to generally refer
to one or more of the Prevention Review Council, the Product Development
Review Council, or Scientific Review Council.
(60) Scientific Research and Prevention Programs Committee--a
group of experts in the field of Cancer Research, Cancer Prevention
or Product Development, including trained Patient Advocates, appointed
by the Chief Executive Officer and approved by the Oversight Committee
for the purpose of conducting Peer Review of Grants Applications and
recommending Grant Awards. A Peer Review Panel is a Scientific Research
and Prevention Programs Committee, as is a Review Council.
(61) Scientific Research and Prevention Programs Committee
Member--an individual appointed by the Chief Executive Officer and
approved by the Oversight Committee to serve on a Scientific Research
and Prevention Programs Committee. Peer Review Panel Members are Scientific
Research and Prevention Programs Committee Members, as are Review
Council Members.
(62) Scientific Review Council--the group of Scientific
Research and Prevention Programs Committee Members designated as the
chairpersons of the Peer Review Panels that review Cancer Research
Grant Applications. This group includes the Review Council chairperson.
(63) Scope of Work--the goals and objectives of the
Cancer Research or Cancer Prevention project, including the timeline
and milestones to be achieved.
(64) Senior Member or Key Personnel--the Principal
Investigator, Project Director or Company Representative and other
individuals who contribute to the scientific development or execution
of a project in a substantive, measurable way, whether or not the
individuals receive salary or compensation under the Grant Award.
(65) Technology--any and all of the following resulting
or arising from work funded by the Grant Award:
(A) Inventions;
(B) Third-Party Information, including but not limited
to data, trade secrets and know-how;
(C) databases, compilations and collections of data;
(D) tools, methods and processes; and
(E) works of authorship, excluding all scholarly works,
but including, without limitation, computer programs, source code
and executable code, whether embodied in software, firmware or otherwise,
documentation, files, records, data and mask works; and all instantiations
of the foregoing in any form and embodied in any form, including but
not limited to therapeutics, drugs, drug delivery systems, drug formulations,
devices, diagnostics, biomarkers, reagents and research tools.
(66) Texas Cancer Plan--a coordinated, prioritized,
and actionable framework that helps to guide statewide efforts to
fight the human and economic burden of cancer in Texas.
(67) Third-Party Information--generally, all trade
secrets, proprietary information, know-how and non-public business
information disclosed to the Institute by Grant Applicant, Grant Recipient,
or other individual external to the Institute.
(68) Tobacco--all forms of tobacco products, including
but not limited to cigarettes, cigars, pipes, water pipes (hookah),
bidis, kreteks, electronic cigarettes, smokeless tobacco, snuff and
chewing tobacco.
|